First Patient Enrolled in Prospective Randomized Trial with Erectile Dysfunction Using SELUTION SLR
Geneva, Switzerland, September 10, 2022 /PRNewswire/ — An 82-year-old Taiwanese man becomes the first patient to be enrolled in the first erectile dysfunction (ED) randomized clinical trial (RCT) involving SELUTION SLR™, MedAlliance’s new sirolimus-eluting balloon I was. First Patient Enrolled in Prospective Randomized Trial with Erectile Dysfunction Using SELUTION SLR Perfect Selection FIM (PERivic R.Hemostasis … Read more